BB Biotech invests in fast-growing biotechnology companies that are developing and marketing innovative drugs. It focuses on biotech companies whose products address areas of significant unmet medical needs and thus have above-average sales and profit-growth potential.
The renowned Board of Directors of BB Biotech AG has many years of industrial and scientific experience. A team of proven biotech specialists from Bellevue Asset Management AG takes care of investments in the most attractive biotech companies.
